Guardant Health, Inc. (GH) NASDAQ
130.17
+1.03(+0.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.81B |
| Enterprise Value | 14.11B |
| P/E Ratio | -39.45 |
| PEG Ratio | 114.78 |
| Price/Sales Ratio | 15.98 |
| Price/Book Ratio | -94.37 |
| Enterprise/Revenue | 16.61 |
| Enterprise/EBITDA | -45.9 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.4 |
| Operating Margin | -0.41 |
Management Effectiveness
| Return On Assets | -0.23 |
| Return On Equity | 1.84 |
Income Statement
| Revenue | 982.02M |
| Revenue/Share | 8.23 |
| Gross Profit | 633.01M |
| EBITDA | -373.91M |
| Net Income | -416.28M |
| Diluted EPS | -3.32 |
Balance Sheet
| Total Cash | 1.1B |
| Total Cash/Share | 8.4 |
| Total Debt | 1.68B |
| Total Debt/Equity | -9.26 |
| Current Ratio | 4.68 |
| Book Value Per Share | -1.38 |
Price History
| 52-Week Change | 209.19 |
| 52-Week High | 133.97 |
| 52-Week Low | 40.35 |
| Moving Average 50 Days | 95.2 |
| Moving Average 200 Days | 89.53 |
Statistics
| Average Volume | 2.13M |
| Shares Outstanding | 132.6M |
| % Held by Institutions | 106.76 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
